3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
5
Prostatic Neoplasms
3
Urogenital Neoplasms
2
Pancreatic Neoplasms
2
Endometrial Neoplasms
2
Colorectal Neoplasms, Hereditary Nonpolyposis
2
Colorectal Neoplasms
2
Brain Neoplasms
2
Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8
1
Wilms Tumor
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Neurofibromatosis 1
1
Neoplasms, Unknown Primary
1
Neoplasm Metastasis
1
Kidney Neoplasms
1
Hot Flashes
1
Head and Neck Neoplasms
1
Genetic Predisposition to Disease
1
Dyslexia
1
Digestive System Neoplasms
1
Depression
1
Colonic Neoplasms
1
Central Nervous System Neoplasms
1
Advanced Malignant Neoplasm
1
Interventions
Gemcitabine
74
Capecitabine
60
Paclitaxel
59
Fluorouracil
58
Oxaliplatin
57
Bevacizumab
51
Docetaxel
50
Leucovorin
48
Nivolumab
40
Cisplatin
40
Irinotecan
39
Carboplatin
37
Cetuximab
33
pembrolizumab
32
Radiosurgery
32
Trastuzumab
30
Radiotherapy
27
Everolimus
24
Sorafenib
23
Pemetrexed
20
Doxorubicin
20
Albumin-Bound Paclitaxel
20
Ipilimumab
19
Cyclophosphamide
19
Panitumumab
18
Zoledronic Acid
17
Lapatinib
17
Erlotinib Hydrochloride
17
Prednisone
16
pazopanib
15
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Neoplasm Metastasis
×
Genetic Testing
×
Clear all
NCT01460186
2019-01-15
StoRM
Centre Leon Berard
Phase NA
Completed
1,000 enrolled